Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blood

Showing results (971-980 of 39,482) with videos related to

Pageof 3,949
Sort By:
Blood|August 1, 2002
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720Maria R Baer, Stephen L George, Richard K Dodge, et al.
Blood|August 1, 2002
Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destructionChristoph Uherek, Torsten Tonn, Barbara Uherek, et al.
Blood|August 1, 2002
Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathwayJesus Pérez-Losada, Manuel Sánchez-Martín, Arancha Rodríguez-García, et al.
Blood|August 1, 2002
Role of p38 and ERK MAP kinase in proliferation of erythroid progenitors in response to stimulation by soluble and membrane isoforms of stem cell factorReuben Kapur, Saurabh Chandra, Ryan Cooper, et al.
Blood|August 1, 2002
Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9 gliomasYijun Chen, Thomas Douglass, Edward W B Jeffes, et al.
Blood|August 1, 2002
V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemiaAlexander Kröber, Till Seiler, Axel Benner, et al.
Blood|August 1, 2002
ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphomaKirsten Grønbaek, Jesper Worm, Elisabeth Ralfkiaer, et al.
Blood|August 1, 2002
Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemiaJin Hong Liu, Sheng Wei, Thierry Lamy, et al.
Blood|August 1, 2002
An exon 10 deletion in the mouse ferrochelatase gene has a dominant-negative effect and causes mild protoporphyriaScott T Magness, Nobuyo Maeda, David A Brenner
Blood|August 1, 2002
Increased presence of anti-HLA antibodies early after allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood hematopoietic stem cell transplantation compared with bone marrow transplantationValérie Lapierre, Anne Aupérin, Hakim Tayebi, et al.
Pageof 3,949

Showing results (971-980 of 39,482) with videos related to

Sort By:
Pageof 3,949
Blood|August 1, 2002
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720Maria R Baer, Stephen L George, Richard K Dodge, et al.
Blood|August 1, 2002
Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destructionChristoph Uherek, Torsten Tonn, Barbara Uherek, et al.
Blood|August 1, 2002
Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathwayJesus Pérez-Losada, Manuel Sánchez-Martín, Arancha Rodríguez-García, et al.
Blood|August 1, 2002
Role of p38 and ERK MAP kinase in proliferation of erythroid progenitors in response to stimulation by soluble and membrane isoforms of stem cell factorReuben Kapur, Saurabh Chandra, Ryan Cooper, et al.
Blood|August 1, 2002
Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9 gliomasYijun Chen, Thomas Douglass, Edward W B Jeffes, et al.
Blood|August 1, 2002
V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemiaAlexander Kröber, Till Seiler, Axel Benner, et al.
Blood|August 1, 2002
ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphomaKirsten Grønbaek, Jesper Worm, Elisabeth Ralfkiaer, et al.
Blood|August 1, 2002
Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemiaJin Hong Liu, Sheng Wei, Thierry Lamy, et al.
Blood|August 1, 2002
An exon 10 deletion in the mouse ferrochelatase gene has a dominant-negative effect and causes mild protoporphyriaScott T Magness, Nobuyo Maeda, David A Brenner
Blood|August 1, 2002
Increased presence of anti-HLA antibodies early after allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood hematopoietic stem cell transplantation compared with bone marrow transplantationValérie Lapierre, Anne Aupérin, Hakim Tayebi, et al.
Pageof 3,949